The Registry of Toxic Effects of Chemical Substances
Acetamide, N,N - dimethyl - |
UPDATE: November 2004 | MW: 87.14 | MF: C4H9NO |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
eye | rabbit
100 mg
|
mild
|
DCTODJ 9,147,1986
|
skin | rabbit
10 mg/24 hour open irritation test
|
mild
|
AIHAAP 23,95,1962
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
DNA inhibition
|
unreported route | mouse
4,400 mg/kg
|
APHGAO 56,97,1986
|
sister chromatid exchange
|
hamster
ovary
|
10 gm/L
|
APHGAO 56,97,1986
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | rat
lowest published toxic concentration: 288 ppm/6 hour (10 day male)
|
Reproductive: Paternal effects: Testes, epididymis, sperm duct
|
TOXID9 4,65,1984
|
inhalation | rat
lowest published toxic concentration: 281 ppm/6 hour (6-15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
TJADAB 29(2),59A,1984
|
inhalation | rat
lowest published toxic concentration: 300 ppm/6 hour (10 week prior to copulation-3 week after birth)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
|
FAATDF 7,132,1986
|
inhalation | rat
lowest published toxic concentration: 282 ppm/6 hour (6-15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
FAATDF 16,414,1991
|
inhalation | rat
lowest published toxic concentration: 282 ppm (6-15 day pregnant)
|
Reproductive: Other effects on female | Reproductive: Other effects to embryo or fetus
CRTXB2 31,139,2001
|
inhalation | rabbit
lowest published toxic concentration: 570 ppm (7-19 day pregnant)
|
Reproductive: Other effects to embryo or fetus
|
CRTXB2 31,139,2001
|
intraperitoneal | rat
lowest published toxic dose: 2 mg/kg (1 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
85DJA5 -,95,1971
|
oral | rat
lowest published toxic dose: 5,600 mg/kg (6-19 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
FAATDF 9,550,1987
|
oral | rat
lowest published toxic dose: 5,600 mg/kg (6-19 day pregnant)
|
Reproductive: Specific developmental abnormalities: Musculoskeletal system | Reproductive: Specific developmental abnormalities: Cardiovascular (circulatory) system Reproductive: Specific developmental abnormalities: Homeostasis
FAATDF 9,550,1987
|
oral | rat
lowest published toxic dose: 5,600 mg/kg (6-19 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on embryo or fetus: Fetal death
CRTXB2 31,139,2001
|
oral | rat
lowest published toxic dose: 2,240 mg/kg (6-19 day pregnant)
|
Reproductive: Other effects on female | Reproductive: Other effects to embryo or fetus
CRTXB2 31,139,2001
|
oral | rat
lowest published toxic dose: 5,600 mg/kg (6-19 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue) Reproductive: Specific developmental abnormalities: Cardiovascular (circulatory) system
CRTXB2 31,139,2001
|
oral | rat
lowest published toxic dose: 6 gm/kg (7-21 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system | Reproductive: Specific developmental abnormalities: Musculoskeletal system Reproductive: Specific developmental abnormalities: Cardiovascular (circulatory) system
CRTXB2 31,139,2001
|
oral | rabbit
lowest published toxic dose: 3,900 mg/kg (6-18 day pregnant)
|
Reproductive: Specific developmental abnormalities: Eye, ear | Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue) Reproductive: Specific developmental abnormalities: Musculoskeletal system
ARZNAD 30,1557,1980
|
oral | rabbit
lowest published toxic dose: 3,900 mg/kg (6-18 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
ARZNAD 30,1557,1980
|
skin | rat
lowest published toxic dose: 2,400 mg/kg (10-11 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetal death | Reproductive: Specific developmental abnormalities: Central nervous system
TXAPA9 41,35,1977
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | mammal (species unspecified)
lowest published lethal concentration: 406 ppm
|
Liver: Fatty liver degeneration
|
TXAPA9 3,12,1961
|
inhalation | mouse
lethal concentration (50 percent kill): 7,200 mg/m3
|
Behavioral: Ataxia | Lung, Thorax, or Respiration: Other changes Liver: Other changes
CHYCDW 13,29,1979
|
inhalation | rat
lethal concentration (50 percent kill): 2,475 ppm/1 hour
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
DCTODJ 9,147,1986
|
intraperitoneal | mouse
lethal dose (50 percent kill): 2,800 mg/kg
|
N/R
|
YKIGAK 31,327,1980
|
intraperitoneal | rat
lethal dose (50 percent kill): 2,750 mg/kg
|
N/R
|
JRPFA4 4,219,1962
|
intravenous | chicken
lowest published lethal dose: 12 gm/kg
|
N/R
|
ARZNAD 20,1242,1970
|
intravenous | mouse
lethal dose (50 percent kill): 3,020 mg/kg
|
N/R
|
ARZNAD 26,1581,1976
|
intravenous | rat
lethal dose (50 percent kill): 2,640 mg/kg
|
N/R
|
ARZNAD 26,1581,1976
|
intravenous | rabbit
lowest published lethal dose: 8,340 mg/kg
|
N/R
|
ARZNAD 20,1242,1970
|
oral | mouse
lethal dose (50 percent kill): 4,620 mg/kg
|
N/R
|
ARZNAD 26,1581,1976
|
oral | rat
lethal dose (50 percent kill): 4,300 mg/kg
|
N/R
|
GISAAA 45(6),76,1980
|
skin | mouse
lethal dose (50 percent kill): 9,600 mg/kg
|
Behavioral: Food intake (animal) | Lung, Thorax, or Respiration: Other changes Liver: Other changes
CHYCDW 13,29,1979
|
skin | rat
lethal dose (50 percent kill): >2 gm/kg
|
N/R
|
EPASR* 8EHQ-1190-0981
|
skin | rabbit
lethal dose (50 percent kill): 2,240 mg/kg
|
Skin: After topical application: Primary irritation
|
AIHAAP 23,95,1962
|
unreported route | rat
lethal dose (50 percent kill): 3 gm/kg
|
N/R
|
ARZNAD 19,1073,1969
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | mouse
lowest published toxic concentration: 700 mg/m3/4 hour/2 week- intermittent
|
Blood: Pigmented or nucleated red blood cells | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
INHTE5 9,141,1997
|
inhalation | mouse
lowest published toxic concentration: 375 ppm/6 hour/78 week- intermittent
|
Eye: Retinal changes pigmentary deposition, retinitis, other) | Liver: Other changes Liver: Changes in liver weight
FAATDF 28,80,1995
|
inhalation | rat
lowest published toxic dose: 103 ppm/6 hour/26 week- intermittent
|
Liver: Other changes
|
TXAPA9 3,12,1961
|
inhalation | rat
lowest published toxic concentration: 300 ppm/6 hour/12 day- intermittent
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Biochemical: Metabolism (intermediary): Lipids including transport
DCTODJ 16,175,1993
|
inhalation | rat
lowest published toxic concentration: 120 ppm/6 hour/64 day- intermittent
|
Liver: Changes in liver weight
|
JTEHD6 27,297,1989
|
inhalation | rat
lowest published toxic concentration: 100 ppm/6 hour/2 year- intermittent
|
Liver: Other changes
|
FAATDF 28,80,1995
|
oral | rat
lowest published toxic dose: 15 gm/kg/10 day- continuous
|
Gastrointestinal: Other changes | Liver: Other changes Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
NTIS** OTS0572893
|
oral | rat
lowest published toxic dose: 364 mg/kg/26 week- intermittent
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other esterases Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
GISAAA 45(6),76,1980
|
oral | rat
lowest published toxic dose: 4,500 mg/kg/90 day- continuous
|
Blood: Changes in erythrocyte (RBC) count | Blood: Changes in leukocyte (WBC) count
DCTODJ 9,147,1986
|
skin | dog
lowest published toxic dose: 113 gm/kg/6 week- intermittent
|
Liver: Fatty liver degeneration | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
TXAPA9 3,12,1961
|
skin | rabbit
lowest published toxic dose: 8 gm/kg/4 day- intermittent
|
Liver: Other changes | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
DCTODJ 9,147,1986
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
time-weighted average 10 ppm (skin)
|
DTLVS* TLV/BEI,2003
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
Not Classifiable as a Human Carcinogen
|
DTLVS* TLV/BEI,2003
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Mine Safety and Health Administration (MSHA) STANDARD - air
|
time-weighted average 10 ppm (35 mg/m3) (skin)
|
DTLVS* 3,88,1971
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry)
|
8 hour time-weighted average 10 ppm (35 mg/m3) (skin)
|
CFRGBR 29,1910.1000,1994
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction)
|
8 hour time-weighted average 10 ppm (35 mg/m3) (skin)
|
CFRGBR 29,1926.55,1994
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards)
|
8 hour time-weighted average 10 ppm (35 mg/m3) (skin)
|
CFRGBR 29,1915.1000,1993
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors)
|
8 hour time-weighted average 10 ppm (35 mg/m3) (skin)
|
CFRGBR 41,50-204.50,1994
|
Occupational Exposure Limit - AUSTRALIA
|
time-weighted average 10 ppm (35 mg/m3), Skin, JAN1993
|
Occupational Exposure Limit - AUSTRIA
|
MAK 10 ppm (35 mg/m3), Skin, JAN1999
|
Occupational Exposure Limit - BELGIUM
|
time-weighted average 10 ppm (36 mg/m3), Skin, JAN1993
|
Occupational Exposure Limit - DENMARK
|
time-weighted average 10 ppm (35 mg/m3), Skin, JAN1999
|
Occupational Exposure Limit - FINLAND
|
time-weighted average 10 ppm (35 mg/m3), short term exposure limit 20 ppm (70 mg/m3), Skin, JAN1993
|
Occupational Exposure Limit - FRANCE
|
VME 10 ppm (35 mg/m3), Skin, JAN1999
|
Occupational Exposure Limit - GERMANY
|
MAK 10 ppm (35 mg/m3), Skin, JAN1999
|
Occupational Exposure Limit - JAPAN
|
Occupational Exposure Limit 10 ppm (36 mg/m3), Skin, JAN1999
|
Occupational Exposure Limit - THE NETHERLANDS
|
MAC-TGG 36 mg/m3, Skin, 2003
|
Occupational Exposure Limit - NORWAY
|
time-weighted average 10 ppm (35 mg/m3), JAN1999
|
Occupational Exposure Limit - THE PHILIPPINES
|
time-weighted average 10 ppm (35 mg/m3), Skin, JAN1993
|
Occupational Exposure Limit - POLAND
|
MAC(time-weighted average) 35 mg/m3, JAN1999
|
Occupational Exposure Limit - SWITZERLAND
|
MAK- week 10 ppm (35 mg/m3), KZG- week 20 ppm (70 mg/m3), Skin, JAN1999
|
Occupational Exposure Limit - UNITED KINGDOM
|
time-weighted average 10 ppm (36 mg/m3), short term exposure limit 20 ppm (72 mg/m3), Skin, SEP2000
|
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value; | Not Classifiable as a Human Carcinogen
Occupational Exposure Limit IN NEW ZEALAND, SINGAPORE, VIETNAM
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value |
Not Classifiable as a Human Carcinogen |
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO DIMETHYL ACETAMIDE-air
|
10 hour time-weighted average 10 ppm (Sk)
|
NIOSH* DHHS #92-100,1992
|
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: 26095; | Number of Industries 5; Total Number of Facilities 66; Number of Occupations 13; Total Number of Employees Exposed 7,658
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: 26095; |
Number of Industries 14; Total Number of Facilities 907; Number of Occupations 27; Total Number of Employees Exposed 28,943; Total Number of Female Employees Exposed 15,028 |
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
Used as a solvent for resins and to make ALKYL DIMETHYLAMINE OXIDE and rubber chemicals
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
NIOSH Analytical Method, 1994: Dimethylacetamide, 2004
|
|
REFERENCES:
CODEN
|
|
REFERENCE
85DJA5
|
"Malformations Congenitales des Mammiferes," Tuchmann-Duplessis, H., Paris, Masson et Cie,
1971
|
AIHAAP
|
American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH
44311) V.19- 1958-
|
APHGAO
|
Acta Pharmaceutica Hungarica. (Kultura, POB 149, H-1389 Budapest, Hungary) 1953- Adopts
V.24 in 1955.
|
ARZNAD
|
Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960
Aulendorf, Fed. Rep. Ger.) V.1- 1951-
|
CFRGBR
|
Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents,
Washington, DC 20402)
|
CHYCDW
|
Zhonghua Yufangyixue Zazhi. Chinese Journal of Preventive Medicine. (China International
Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) Beginning history not known.
|
CRTXB2
|
CRC Critical Reviews in Toxicology. (CRC Press, Inc., 2000 Corporate Blvd., NW, Boca Raton,
FL 33431) V.1- 1971-
|
DCTODJ
|
Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1-
1977/78-
|
DTLVS*
|
The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by
American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996
|
EPASR*
|
United States Environmental Protection Agency, Office of Pesticides and Toxic Substances.
(U.S. Environmental Protection Agency, 401 M St., SW, Washington, DC 20460) History unknown.
|
FAATDF
|
Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1-40, 1981-97. For publisher information, see TOSCF2
|
GISAAA
|
Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga,
113095 Moscow, USSR) V.1- 1936-
|
INHTE5
|
Inhalation Toxicology. (Published by Taylor & Francis Health, 11 New Fetter Lane, London EC4P
4EE) V.1- 1989-
|
JRPFA4
|
Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way,
Colchester, Essex CO2 8HP, UK) V.1- 1960-
|
JTEHD6
|
Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW,
Washington, DC 20005) V.1- 1975/76-
|
NIOSH*
|
National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and
Welfare, Reports and Memoranda.
|
NTIS**
|
National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse
for Scientific & Technical Information.
|
TJADAB
|
Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E.
11th St., New York, NY 10003) V.1- 1968-
|
TOXID9
|
Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1-
1981-
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
YKIGAK
|
Yokohama Igaku. Yokohama Medicine. (Yokohama-Shiritsu Daigaku Igakkai, 2-33 Urafune-cho,
Minami-ku, Yokohama 232, Japan) V.1- 1948-
|
|